EMA and NICE Appraisal Processes for Cancer Drugs: Current Status and Uncertainties

Rumona Dickson; Angela Boland; Rui Duarte; Eleanor Kotas; Nerys Woolacott; Robert Hodgson; Rob Riemsma; Sabine Grimm; Bram Ramaekers; Manuela Joore; Nasuh Buyukkaramikli; Eva Kaltenthaler; Matt Stevenson; Abdullah Pandor; Steve Edwards; Martin Hoyle; Jonathan Shepherd; Xavier Armoiry; Miriam Brazzelli

doi:10.1007/s40258-018-0393-7

EMA and NICE Appraisal Processes for Cancer Drugs: Current Status and Uncertainties

Rumona Dickson^*, Angela Boland, Rui Duarte, Eleanor Kotas, Nerys Woolacott, Robert Hodgson, Rob Riemsma, Sabine Grimm, Bram Ramaekers, Manuela Joore, Nasuh Buyukkaramikli, Eva Kaltenthaler, Matt Stevenson, Abdullah Pandor, Steve Edwards, Martin Hoyle, Jonathan Shepherd, Xavier Armoiry, Miriam Brazzelli

^*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	429-432
Number of pages	4
Journal	Applied Health Economics and Health Policy
Volume	16
Issue number	4
DOIs	https://doi.org/10.1007/s40258-018-0393-7
Publication status	Published - 1 Aug 2018

Access to Document

10.1007/s40258-018-0393-7Licence: CC BY

https://link.springer.com/content/pdf/10.1007%2Fs40258-018-0393-7.pdf

Cite this

Dickson, R., Boland, A., Duarte, R., Kotas, E., Woolacott, N., Hodgson, R., Riemsma, R., Grimm, S., Ramaekers, B., Joore, M., Buyukkaramikli, N., Kaltenthaler, E., Stevenson, M., Pandor, A., Edwards, S., Hoyle, M., Shepherd, J., Armoiry, X., & Brazzelli, M. (2018). EMA and NICE Appraisal Processes for Cancer Drugs: Current Status and Uncertainties. Applied Health Economics and Health Policy, 16(4), 429-432. https://doi.org/10.1007/s40258-018-0393-7

@article{c52b6a4e39994682872fee2cbb4088c0,

title = "EMA and NICE Appraisal Processes for Cancer Drugs: Current Status and Uncertainties",

author = "Rumona Dickson and Angela Boland and Rui Duarte and Eleanor Kotas and Nerys Woolacott and Robert Hodgson and Rob Riemsma and Sabine Grimm and Bram Ramaekers and Manuela Joore and Nasuh Buyukkaramikli and Eva Kaltenthaler and Matt Stevenson and Abdullah Pandor and Steve Edwards and Martin Hoyle and Jonathan Shepherd and Xavier Armoiry and Miriam Brazzelli",

year = "2018",

month = aug,

day = "1",

doi = "10.1007/s40258-018-0393-7",

language = "English",

volume = "16",

pages = "429--432",

journal = "Applied Health Economics and Health Policy",

issn = "1175-5652",

publisher = "Adis International Ltd",

number = "4",

}

Dickson, R, Boland, A, Duarte, R, Kotas, E, Woolacott, N, Hodgson, R, Riemsma, R, Grimm, S , Ramaekers, B , Joore, M, Buyukkaramikli, N, Kaltenthaler, E, Stevenson, M, Pandor, A, Edwards, S, Hoyle, M, Shepherd, J, Armoiry, X & Brazzelli, M 2018, 'EMA and NICE Appraisal Processes for Cancer Drugs: Current Status and Uncertainties', Applied Health Economics and Health Policy, vol. 16, no. 4, pp. 429-432. https://doi.org/10.1007/s40258-018-0393-7

TY - JOUR

T1 - EMA and NICE Appraisal Processes for Cancer Drugs: Current Status and Uncertainties

AU - Dickson, Rumona

AU - Boland, Angela

AU - Duarte, Rui

AU - Kotas, Eleanor

AU - Woolacott, Nerys

AU - Hodgson, Robert

AU - Riemsma, Rob

AU - Grimm, Sabine

AU - Ramaekers, Bram

AU - Joore, Manuela

AU - Buyukkaramikli, Nasuh

AU - Kaltenthaler, Eva

AU - Stevenson, Matt

AU - Pandor, Abdullah

AU - Edwards, Steve

AU - Hoyle, Martin

AU - Shepherd, Jonathan

AU - Armoiry, Xavier

AU - Brazzelli, Miriam

PY - 2018/8/1

Y1 - 2018/8/1

U2 - 10.1007/s40258-018-0393-7

DO - 10.1007/s40258-018-0393-7

M3 - Article

SN - 1175-5652

VL - 16

SP - 429

EP - 432

JO - Applied Health Economics and Health Policy

JF - Applied Health Economics and Health Policy

IS - 4

ER -